Michael L. Meyers
2018
In 2018, Michael L. Meyers earned a total compensation of $1.1M as Chief Medical Officer at Syndax Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,200 |
|---|---|
| Option Awards | $474,785 |
| Salary | $412,000 |
| Other | $20,949 |
| Total | $1,051,934 |
Meyers received $474.8K in option awards, accounting for 45% of the total pay in 2018.
Meyers also received $144.2K in non-equity incentive plan, $412K in salary and $20.9K in other compensation.
Rankings
In 2018, Michael L. Meyers' compensation ranked 8,980th out of 14,244 executives tracked by ExecPay. In other words, Meyers earned more than 37.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,980 out of 14,244 | 37th |
Division Manufacturing | 3,571 out of 5,759 | 38th |
Major group Chemicals And Allied Products | 1,347 out of 2,122 | 37th |
Industry group Drugs | 1,130 out of 1,811 | 38th |
Industry Pharmaceutical Preparations | 879 out of 1,385 | 37th |
Source: SEC filing on April 30, 2019.
Meyers' colleagues
We found two more compensation records of executives who worked with Michael L. Meyers at Syndax Pharmaceuticals in 2018.